SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-061315
Filing Date
2022-05-16
Accepted
2022-05-16 16:11:20
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ttnp-20220331x10q.htm   iXBRL 10-Q 742828
2 EXHIBIT-31.1 ttnp-20220331xex31d1.htm EX-31.1 14770
3 EXHIBIT-32.1 ttnp-20220331xex32d1.htm EX-32.1 8075
  Complete submission text file 0001104659-22-061315.txt   3539563

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20220331.xsd EX-101.SCH 30560
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20220331_cal.xml EX-101.CAL 36901
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20220331_def.xml EX-101.DEF 113128
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20220331_lab.xml EX-101.LAB 232071
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20220331_pre.xml EX-101.PRE 197840
45 EXTRACTED XBRL INSTANCE DOCUMENT ttnp-20220331x10q_htm.xml XML 526807
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 22929065
SIC: 2836 Biological Products, (No Diagnostic Substances)